Efforts to improve consistency in EU notified body performance continue
This article was originally published in RAJ Devices
Executive Summary
The activities of notified bodies in the EU should be closely monitored by the authorities who designate them in order to ensure that the new requirements for assessing technical documentation related to medium-to-high risk (Class IIa/IIb) devices are implemented in a harmonised way1.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.